Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia

N. I. Noguera, E. Ammatuna, D. Zangrilli, S. Lavorgna, M. Divona, F. Buccisano, S. Amadori, C. Mecucci, B. Falini, Francesco Lo-Coco

Research output: Contribution to journalArticle

Abstract

Mutations in the Nucleophosmin (NPM1) gene have been recently described to occur in about one-third of acute myeloid leukemias (AML) and represent the most frequent genetic alteration currently known in this subset. These mutations generate an elongated NPM1 protein that localizes aberrantly in the cytoplasm. In analogy with Flt3 alterations, NPM1 mutations are mostly detectable in AML with normal karyotype and their recognition may be relevant to identify distinct response to treatment. Hence, in addition to conventional karyotyping and RT-PCR of fusion genes, combined analysis of both Flt3 and NPM1 mutations will be increasingly relevant in the genetic diagnosis work-up of AML. We developed a multiplex RT-PCR assay followed by capillary electrophoresis to simultaneously analyze NPM1 and Flt3 gene alterations (NFmPCR assay). The assay was validated in leukemic cell RNAs extracted from 38 AML patients, which had been previously characterized for Flt3 status by conventional RT-PCR. Direct sequencing of NPM1 RT-PCR products was carried out in 15 cases to verify results obtained by capillary electrophoresis. Both NPM1 sequencing and conventional RT-PCR Flt3 results showed 100% concordance with the results of the NFmPCR assay. We suggest that this assay may be introduced in routine analysis of genetic alterations in AML.

Original languageEnglish
Pages (from-to)1479-1482
Number of pages4
JournalLeukemia
Volume19
Issue number8
DOIs
Publication statusPublished - 2005

Fingerprint

Capillary Electrophoresis
Acute Myeloid Leukemia
Mutation
Polymerase Chain Reaction
Karyotyping
Gene Fusion
Multiplex Polymerase Chain Reaction
Karyotype
Genes
Cytoplasm
RNA
Proteins

Keywords

  • Acute myeloid leukemia
  • AML genetic characterization
  • FLT3
  • NPM1

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. / Noguera, N. I.; Ammatuna, E.; Zangrilli, D.; Lavorgna, S.; Divona, M.; Buccisano, F.; Amadori, S.; Mecucci, C.; Falini, B.; Lo-Coco, Francesco.

In: Leukemia, Vol. 19, No. 8, 2005, p. 1479-1482.

Research output: Contribution to journalArticle

Noguera, NI, Ammatuna, E, Zangrilli, D, Lavorgna, S, Divona, M, Buccisano, F, Amadori, S, Mecucci, C, Falini, B & Lo-Coco, F 2005, 'Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia', Leukemia, vol. 19, no. 8, pp. 1479-1482. https://doi.org/10.1038/sj.leu.2403846
Noguera, N. I. ; Ammatuna, E. ; Zangrilli, D. ; Lavorgna, S. ; Divona, M. ; Buccisano, F. ; Amadori, S. ; Mecucci, C. ; Falini, B. ; Lo-Coco, Francesco. / Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. In: Leukemia. 2005 ; Vol. 19, No. 8. pp. 1479-1482.
@article{360ba11626ad49d1baec17498898732f,
title = "Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia",
abstract = "Mutations in the Nucleophosmin (NPM1) gene have been recently described to occur in about one-third of acute myeloid leukemias (AML) and represent the most frequent genetic alteration currently known in this subset. These mutations generate an elongated NPM1 protein that localizes aberrantly in the cytoplasm. In analogy with Flt3 alterations, NPM1 mutations are mostly detectable in AML with normal karyotype and their recognition may be relevant to identify distinct response to treatment. Hence, in addition to conventional karyotyping and RT-PCR of fusion genes, combined analysis of both Flt3 and NPM1 mutations will be increasingly relevant in the genetic diagnosis work-up of AML. We developed a multiplex RT-PCR assay followed by capillary electrophoresis to simultaneously analyze NPM1 and Flt3 gene alterations (NFmPCR assay). The assay was validated in leukemic cell RNAs extracted from 38 AML patients, which had been previously characterized for Flt3 status by conventional RT-PCR. Direct sequencing of NPM1 RT-PCR products was carried out in 15 cases to verify results obtained by capillary electrophoresis. Both NPM1 sequencing and conventional RT-PCR Flt3 results showed 100{\%} concordance with the results of the NFmPCR assay. We suggest that this assay may be introduced in routine analysis of genetic alterations in AML.",
keywords = "Acute myeloid leukemia, AML genetic characterization, FLT3, NPM1",
author = "Noguera, {N. I.} and E. Ammatuna and D. Zangrilli and S. Lavorgna and M. Divona and F. Buccisano and S. Amadori and C. Mecucci and B. Falini and Francesco Lo-Coco",
year = "2005",
doi = "10.1038/sj.leu.2403846",
language = "English",
volume = "19",
pages = "1479--1482",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia

AU - Noguera, N. I.

AU - Ammatuna, E.

AU - Zangrilli, D.

AU - Lavorgna, S.

AU - Divona, M.

AU - Buccisano, F.

AU - Amadori, S.

AU - Mecucci, C.

AU - Falini, B.

AU - Lo-Coco, Francesco

PY - 2005

Y1 - 2005

N2 - Mutations in the Nucleophosmin (NPM1) gene have been recently described to occur in about one-third of acute myeloid leukemias (AML) and represent the most frequent genetic alteration currently known in this subset. These mutations generate an elongated NPM1 protein that localizes aberrantly in the cytoplasm. In analogy with Flt3 alterations, NPM1 mutations are mostly detectable in AML with normal karyotype and their recognition may be relevant to identify distinct response to treatment. Hence, in addition to conventional karyotyping and RT-PCR of fusion genes, combined analysis of both Flt3 and NPM1 mutations will be increasingly relevant in the genetic diagnosis work-up of AML. We developed a multiplex RT-PCR assay followed by capillary electrophoresis to simultaneously analyze NPM1 and Flt3 gene alterations (NFmPCR assay). The assay was validated in leukemic cell RNAs extracted from 38 AML patients, which had been previously characterized for Flt3 status by conventional RT-PCR. Direct sequencing of NPM1 RT-PCR products was carried out in 15 cases to verify results obtained by capillary electrophoresis. Both NPM1 sequencing and conventional RT-PCR Flt3 results showed 100% concordance with the results of the NFmPCR assay. We suggest that this assay may be introduced in routine analysis of genetic alterations in AML.

AB - Mutations in the Nucleophosmin (NPM1) gene have been recently described to occur in about one-third of acute myeloid leukemias (AML) and represent the most frequent genetic alteration currently known in this subset. These mutations generate an elongated NPM1 protein that localizes aberrantly in the cytoplasm. In analogy with Flt3 alterations, NPM1 mutations are mostly detectable in AML with normal karyotype and their recognition may be relevant to identify distinct response to treatment. Hence, in addition to conventional karyotyping and RT-PCR of fusion genes, combined analysis of both Flt3 and NPM1 mutations will be increasingly relevant in the genetic diagnosis work-up of AML. We developed a multiplex RT-PCR assay followed by capillary electrophoresis to simultaneously analyze NPM1 and Flt3 gene alterations (NFmPCR assay). The assay was validated in leukemic cell RNAs extracted from 38 AML patients, which had been previously characterized for Flt3 status by conventional RT-PCR. Direct sequencing of NPM1 RT-PCR products was carried out in 15 cases to verify results obtained by capillary electrophoresis. Both NPM1 sequencing and conventional RT-PCR Flt3 results showed 100% concordance with the results of the NFmPCR assay. We suggest that this assay may be introduced in routine analysis of genetic alterations in AML.

KW - Acute myeloid leukemia

KW - AML genetic characterization

KW - FLT3

KW - NPM1

UR - http://www.scopus.com/inward/record.url?scp=23844546308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844546308&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2403846

DO - 10.1038/sj.leu.2403846

M3 - Article

C2 - 15973451

AN - SCOPUS:23844546308

VL - 19

SP - 1479

EP - 1482

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 8

ER -